About Transave
Transave is a company based in Monmouth Junction (United States) founded in 1997 was acquired by Insmed in December 2010.. Transave has raised $13.04 million across 3 funding rounds from investors including Insmed. Transave operates in a competitive market with competitors including MannKind Corp, aTyr Pharma, ReCode Therapeutics, Impel NeuroPharma and Sirnaomics, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Transave Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transave
Transave has successfully raised a total of $13.04M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $2.0M
-
First Round
First Round
(13 Nov 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2010 | Amount | Series A - Transave | Valuation |
investors |
|
| Jun, 2010 | Amount | Series A - Transave | Valuation |
investors |
|
| Nov, 2009 | Amount | Series A - Transave | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Transave
Transave has secured backing from 1 investor. Prominent investors backing the company include Insmed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of small molecule inhibitors for rare lung diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Transave
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Transave
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transave Comparisons
Competitors of Transave
Transave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, aTyr Pharma, ReCode Therapeutics, Impel NeuroPharma and Sirnaomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Protein biologics are developed for treating rare diseases.
|
|
| domain | founded_year | HQ Location |
Precision medicines for lung-related diseases are developed.
|
|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of products for the treatment of acute and intermittent conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Transave
When was Transave founded?
Transave was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Where is Transave located?
Transave is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Is Transave a funded company?
Transave is a funded company, having raised a total of $13.04M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5.54M, raised on Nov 13, 2009.
What does Transave do?
Transave was founded in 1997 in Monmouth Junction, United States, within the biotechnology sector. Inhaled pharmaceuticals are developed by the company for targeted treatment of serious lung infections. The lead product, ARIKACE (liposomal amikacin for inhalation), is being advanced for cystic fibrosis patients facing Pseudomonas infections and those due to non-tuberculous Mycobacteria. Operations focus on respiratory therapeutics, with development centered in the U.S.
Who are the top competitors of Transave?
Transave's top competitors include MannKind Corp, Sirnaomics and Arcturus Therapeutics.
Who are Transave's investors?
Transave has 1 investor. Key investors include Insmed.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.